Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice

CCUR > College of Kinesiology and Health > Department of Chinese Martial Arts > journal articles > Item 987654321/22929

Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/22929

Title:	Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice
Authors:	Wang, Hsei-Wei Liou, Kuo-Tong Wang, Yea-Hwey Lu, Chung-Kuang Lin, Yun-Lian Lee, I-Jung Huang, Sheng-Teng Tsai, Yuan-Hau Cheng, Yi-Chieh Lin, Hung-Jui Shen, Yuh-Chiang
Contributors:	國術系
Keywords:	ACCUMULATION FOCAL CEREBRAL-ISCHEMIA KAPPA-B NEURONAL INJURY INFARCT VOLUME BRAIN-INJURY ACTIVATION RATS
Date:	2011-10-31
Issue Date:	2012-09-06 14:09:48 (UTC+8)
Abstract:	Ethnopharmacological relevance: Bu-yang Huan-wu decoction (BHD) is a famous traditional Chinese medicine formula that has been used clinically in Asia to treat stroke-induced disability for centuries, but the underlying neuroprotective mechanisms are not fully understood. Aim of the study: In this study, we aim to investigate the mechanisms of action using an integrative neurofunctional and broad genomics approach. Materials and methods: Male ICR mice were subjected to an acute ischemic stroke by inducing a middle cerebral ischemic/reperfusion (CI/R) injury. To examine whether BHD could extend the lifespan of mice with a stroke, we used oral administration of BHD (0.5 and 1.0 g/kg) twice daily starting from 2h after ischemia and compared this with vehicle control treatments, recombinant tissue-type plasminogen activator (rt-PA, 10 mg/kg, iv.), and MK-801 (0.2 mg/kg, i.p.). An integrative neurofunctional and genomic approach was performed to elucidate the underlying molecular mechanisms of BHD. Results: More than 80% of the mice died within 2 days after stroke induction in the vehicle control treatment group. However, the survival rates and life-spans of mice treated with BHD, rt-PA and MK-801 were significantly enhanced as compared to the vehicle-treated CI/R group in all three cases. Mice treated with BHD (1.0 g/kg) showed the greatest protective effect across all groups. BHD successfully restored brain function, ameliorated the cerebral infarction, and significantly improved the neurological deficits of the mice with a stroke. BHD also reduced inflammation, oxidative stress, and apoptosis, as well as improved neurogenesis. The molecular impacts of BHD were assessed by genome-wide transcriptome analysis using brains from the CUR mice. The results showed a total of 377 ischemia-induced probe-sets that were significantly influenced by BHD including 93 probe-sets that were commonly more abundant in BHD-treated and sham mice, and another 284 ischemia-induced probe sets that were suppressed by BHD. Mining the functional modules and genetic networks of these 377 genes revealed a significant upregulation of neuroprotective genes associated with neurogenesis (6 genes) and nervous system development (9 genes), and a significant down-regulation of destructive genes associated with the induction of inflammation (14 genes), apoptosis (15 genes), angiogenesis (11 genes) and blood coagulation (7 genes) by BHD. Conclusions: Our results suggested that BHD is able to protect mice against stroke and extend lifespan primarily through a significant down-regulation of genes involved in inflammation, apoptosis, angiogenesis and blood coagulation, as well as an up-regulation of genes mediating neurogenesis and nervous system development. The changes in expression after treatment with BHD are beneficial after ischemic stroke. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Relation:	JOURNAL OF ETHNOPHARMACOLOGY Volume: 138 Issue: 1 Pages: 22-33
Appears in Collections:	[Department of Chinese Martial Arts] journal articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	718	View/Open

View Licence

Loading...